Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06391489 · ClinicalTrials.gov registry record · NA
HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)
A NA study of Cognitive Dysfunction and Memory Impairment, sponsored by Dartmouth-Hitchcock Medical Center.
- Active
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06391489 is a NA study of Cognitive Dysfunction and Memory Impairment that is active but no longer recruiting, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 10 participants, below the 1,993-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06391489, a NA study of Cognitive Dysfunction and Memory Impairment, is active but no longer recruiting, sponsored by Dartmouth-Hitchcock Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with Post Acute Covid Syndrome (PACS). The main questions it aims to answer are: Can the current HOBSCOTCH program be adapted for people with PACS? Will people with PACS experience improved quality of life similar to that found in people with epilepsy after participating in the HOBSCOTCH program? Participants will be asked to: * attend nine, one-hour virtual (online and/or by telephone) HOBSCOTCH-PACS sessions with a one-on-one certified HOBSCOTCH-PACS coach * complete a brief clinical questionnaire about their diagnosis of PACS * complete seven questionnaires before and after the HOBSCOTCH-PACS sessions about their quality of life, memory and thinking processes (objective and subjective cognition), about their physical and mental health and about autonomic symptoms associated with their diagnosis of PACS * keep a short daily diary (using a smart phone app or on paper) about their PACS symptoms and use of the self-management strategies taught in the HOBSCOTCH-PACS program * complete two brief surveys to assess satisfaction with their experience after the entire HOBSCOTCH-PACS program
Conditions Studied
Interventions
- BEHAVIORAL HOBSCOTCH-PACS
Study Locations (1)
New Hampshire
- Dartmouth-Hitchcock - Lebanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2024-05-14 |
| Est. Completion | 2026-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06391489
The ClinicalTrials.gov registry entry for NCT06391489 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,993-participant average among 45 other Cognitive Dysfunction trials with a reported enrollment target (99% lower). The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Cognitive Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which HOBSCOTCH-PACS is the first listed.
NCT06391489 reports 1 study location spanning 1 distinct geographic area - top geographies include New Hampshire.
Frequently Asked Questions
What is clinical trial NCT06391489 about?
NCT06391489 is a clinical study titled "HOBSCOTCH for People With Post Acute COVID-19 Syndrome (PACS)". The goal of this pilot study is to assess the feasibility of adapting and delivering the existing home-based epilepsy self-management intervention, HOBSCOTCH, for people with Post Acute Covid Syndrome (PACS). The main questions it aims to answer are: Can the current HOBSCOTCH program be adapted fo...
What is the current status of trial NCT06391489?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2024-05-14. Estimated completion is 2026-12.
What conditions does trial NCT06391489 study?
This clinical trial studies the following conditions: Cognitive Dysfunction, Memory Impairment, Post-Acute COVID-19 Syndrome, Memory Dysfunction.
What interventions are being tested in trial NCT06391489?
The interventions under investigation include: HOBSCOTCH-PACS (BEHAVIORAL).
Who is sponsoring clinical trial NCT06391489?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06391489 being conducted?
This trial has 1 study location across New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cognitive Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits
RECRUITING · NA
-
Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment
RECRUITING · NA
-
High-Intensity Exercise to Combat Vascular and Cognitive Dysfunction in Adults With HIV
RECRUITING · NA
-
Long COVID Brain Fog: Cognitive Rehabilitation Trial
RECRUITING · NA
-
Up-2 Study: Cognitively Engaging Walking Exercise and Neuromodulation to Enhance Brain Function in Older Adults
RECRUITING · NA
-
Strengthening Neuro-Cognitive Skills for Success in School, Work and Beyond
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.